Simon has more than 25 years’ experience working as a European and UK patent attorney working in the life sciences sector. He provides clear and practical advice on all aspects of patents and other IP rights including drafting, prosecution, inter partes proceedings and due diligence. He is regularly involved in oppositions and appeals at the European Patent Office and covers a wide variety of technical fields, including physical biochemistry, therapeutics, diagnostics, genetics, chemistry and mechanical subject matter.
Areas of Expertise
Clients
Simon’s clients include individual inventors, universities, spin-outs, SMEs, technology transfer organisations, charities and multinational companies in Europe, US and other jurisdictions.
Background
Simon has a BSc (Hons.) degree and PhD in biochemistry from the University of Bristol. He worked for the UK Ministry of Defence intellectual property rights department before joining Mewburn Ellis LLP in 1997, qualifying as a European Patent Attorney in 1996 and Chartered Patent Attorney in 1997. He joined the partnership in 1999.
Simon sits on the Life Sciences Committee of the UK Chartered Institute of Patent Attorneys (CIPA). He has been an examiner for the CIPA qualification exams and is a Member of the Editorial Board of Life Sciences Intellectual Property Review.
Recommendations
Simon has repeatedly been recognised in The Legal 500, Chambers & Partners, Who’s Who Legal, Managing Intellectual Property, IAM Patent 1000 and other directories. He is described as a “European patent attorney whose first-class achievements garner pan-continental acclaim” and a "leader in his field”, with "peers speaking warmly of his character and ability".
Listed in the EPO Rankings short list of recommended attorneys - IAM Patent 1000, 2016 – 2022.
"Simon Kremer understands our work fully and can probe us on any new material. He is also able to oversee the consistent approach in our intellectual property portfolio." - The Legal 500, 2022
"The very approachable" Simon (Kremer) is described as "an authority on the pharmaceutical lifecycle, whose scientific prowess is lauded by the universities he works with" - IAM patent 1000 2020